<DOC>
	<DOCNO>NCT01236781</DOCNO>
	<brief_summary>This multicenter trial use Hologic digital mammography unit evaluate specificity 2-D full field digital mammography ( FFDM ) versus combination 2-D 3-D tomosynthesis image breast cancer screen . Specificity , study , measure participant call-back rate modality . Varying combination 2-D mammography tomosynthesis projection evaluate optimize screen paradigm limit radiation exposure tomosynthesis incorporate . Both prospective retrospective image data assess . Hypothesis : Digital breast tomography ( DBT ) improve specificity breast cancer screen measure reduction call-back rate maintain sensitivity cancer detection . This improved accuracy achieve optimization image sequence number view obtain capped radiation dose combine DBT 2-D screening sequence .</brief_summary>
	<brief_title>Comparison Full-Field Digital Mammography With Digital Breast Tomography Screening Call-Back Rates</brief_title>
	<detailed_description>Asymptomatic woman 25 year old history breast cancer recruit prospective population patient schedule screen mammography ( Group A ) . A similar population woman call back screen 2-D FFDM-detected abnormality also recruit provide enrich population true-positive false-positive 2-D FFDM tomosynthesis case ( Group B ) . Pregnant woman , woman unable tolerate compression breast associate mammography , woman implant , woman breast large accommodate adequate positioning breast DBT exclude trial participation . A total 550 participant recruit -- 500 woman enroll collection prospective imaging data trial ( Group A ) ; 50 additional participant , recall diagnostic assessment positive screening finding , recruit DBT image data collection retrospective image analysis ( Group B ) . Participating institution trial clinical research institution Pennsylvania Hologic tomosynthesis unit .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Women 25 year age old ; No history breast cancer ; Group A : Asymptomatic schedule screen mammography ; Group B : Asymptomatic recall diagnostic testing due positive finding recent screen use FFDM , complete within 30 day prior registration ( BIRADS 0 : additional imaging need ) ; Willing provide write informed consent . Pregnancy intent become pregnant ; Unable unwilling tolerate compression associate mammography ; Breast implant ; Breasts large allow adequate positioning DBT examination ; Group B : Patients FFDM take screen unwilling unable submit image ACRIN ; Group B : Unwilling undergo tomosynthesis breast well potentially additional diagnostic imaging base tomosynthesis finding ; Unable unwilling complete screening ( necessary ) diagnostic image facility ; Tomosynthesis mammography within 11 month prior registration ( exclude screen mammography require Group B ) .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>screen</keyword>
	<keyword>diagnostics</keyword>
	<keyword>diagnosis</keyword>
	<keyword>high-risk</keyword>
	<keyword>breast neoplasm</keyword>
	<keyword>digital mammography</keyword>
	<keyword>mammography</keyword>
	<keyword>tomosynthesis</keyword>
	<keyword>dense breast</keyword>
	<keyword>radiation dose</keyword>
	<keyword>comparison</keyword>
	<keyword>Hologic</keyword>
	<keyword>Pennsylvania</keyword>
	<keyword>Philadelphia</keyword>
	<keyword>breast study</keyword>
	<keyword>mammo</keyword>
	<keyword>tomo</keyword>
	<keyword>mammary</keyword>
</DOC>